CD4 percentage is an independent predictor of survival in patients starting antiretroviral therapy with absolute CD4 cell counts between 200 and 350 cells/μL
Authors:
Open Access
- 24 July 2006
- journal article
- Published by Wiley in HIV Medicine
- Vol. 7 (6) , 383-388
Abstract
Objective: To determine the prognostic value of baseline CD4 percentage in terms of patient survival in comparison to absolute CD4 cell counts for HIV‐positive patients initiating highly active antiretroviral therapy (HAART).Methods: A population‐based cohort study of 1623 antiretroviral therapy‐naïve HIV‐positive individuals who initiated HAART between 1 August 1996 and 30 June 2002 was conducted. Cumulative mortality rates were estimated using Kaplan–Meier methods. Cox proportional hazards regression was used to model the effect of baseline CD4 strata and CD4 percentage strata and other prognostic variables on survival. A subgroup analysis was conducted on 417 AIDS‐free subjects with baseline CD4 counts between 200 and 350 cells/μL.Results: In multivariate models, low CD4 percentages were associated with increased risk of death [CD4%P100 000 HIV‐1 RNA copies/mL were associated with an increased risk of death.Conclusion: CD4 percentages below 15% are independent predictors of mortality in AIDS‐free patients starting HAART, including those with CD4 counts between 200 and 350 cells/μL. CD4 percentage should be considered for inclusion in guidelines used to determine when to start therapy.Keywords
This publication has 8 references indexed in Scilit:
- Absolute CD4 Vs. CD4 Percentage for Predicting the Risk of Opportunistic Illness in HIV InfectionJAIDS Journal of Acquired Immune Deficiency Syndromes, 2004
- Treatment for Adult HIV InfectionJAMA, 2004
- Effect of Medication Adherence on Survival of HIV-Infected Adults Who Start Highly Active Antiretroviral Therapy When the CD4+ Cell Count Is 0.200 to 0.350 × 109 cells/LAnnals of Internal Medicine, 2003
- Higher Baseline Levels of Plasma Human Immunodeficiency Virus Type 1 RNA Are Associated with Increased Mortality after Initiation of Triple‐Drug Antiretroviral TherapyThe Journal of Infectious Diseases, 2003
- Intermittent use of triple-combination therapy is predictive of mortality at baseline and after 1 year of follow-upAIDS, 2002
- Rates of Disease Progression by Baseline CD4 Cell Count and Viral Load After Initiating Triple-Drug TherapyJAMA, 2001
- Early Clinical Markers and CD4 Percentage in Subjects with Human Immunodeficiency Virus InfectionJAIDS Journal of Acquired Immune Deficiency Syndromes, 1996
- CD4% is the best predictor of development of AIDS in a cohort of HIV-infected homosexual menAIDS, 1991